ATLASArmata Pharmaceuticals (ARMP) earnings date: Nov 11, 2026
Armata Pharmaceuticals (ARMP) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 11, 2026, after the close. Analysts expect EPS of -$0.57.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on ARMP
| Last price | $3.28 (+0.9%) |
|---|---|
| Normal 1-day range (±1σ) | ±6.2% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Armata Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Armata Pharmaceuticals reports on Nov 11, 2026. One email the day before, with ATLAS’s read on Armata Pharmaceuticals. You can switch it off at any time.
Alert me before ARMP reportsFree to start. Creating an account takes under a minute.
ARMP earnings at a glance
| Next report (confirmed) | Wed, Nov 11, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.57 |
| Last report | Aug 12, 2026 · Beat |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | -125.7% |
| Average move around a report | ±10.0% (last 4) |
| Sector | Healthcare · Biotechnology |
Armata Pharmaceuticals earnings history: last 4 reports
Armata Pharmaceuticals last reported on Aug 12, 2026: EPS of $1.20 against an estimate of -$0.44 (+372.7% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 12, 2026 | -$0.44 | $1.20 | +372.7% | Beat | +13.4% |
| Jul 23, 2026 | $3.32 | $3.52 | +6.0% | Beat | -11.1% |
| May 13, 2026 | -$0.38 | -$3.16 | -731.6% | Miss | -8.9% |
| Mar 24, 2026 | -$0.40 | -$1.00 | -150.0% | Miss | +6.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ARMP
See the fair value, the probability range and the earnings history of Armata Pharmaceuticals on its ATLAS page.
Armata Pharmaceuticals (ARMP) stock analysisPlans from €3.99 a month.
Armata Pharmaceuticals earnings: frequently asked questions
When does Armata Pharmaceuticals (ARMP) report earnings?
Armata Pharmaceuticals is scheduled to report on Wednesday, November 11, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for ARMP?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.57 per share (USD). Estimates can change before the report.
How often does ARMP beat earnings estimates?
Of its last 4 reports with a recorded result, Armata Pharmaceuticals beat the EPS estimate 2 times; the average surprise was -125.7%. Past results do not predict the next one.
How much does ARMP move around earnings?
Over its last 4 reports the stock moved an average of 10.0% (absolute, from the close before the report day to the close after it), and finished higher 2 of 4 times.
Did Armata Pharmaceuticals beat earnings estimates last quarter?
Armata Pharmaceuticals last reported on Aug 12, 2026: EPS of $1.20 against an estimate of -$0.44 (+372.7% surprise), a beat.
How much does ARMP usually move in a day?
On a normal trading day the ATLAS model puts ARMP’s one-day range at about ±6.2%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 11, 2026
Educational information, not investment advice. Disclaimer